Rapid Increase in Estimated Number of Persons with Atrial Fibrillation in Japan: An Analysis from National Surveys on Cardiovascular Diseases in 1980, 1990 and 2000

Ohsawa, Masaki; Okayama, Akira; Sakata, Kiyomi; Kato, Karen; Itai, Kazuyoshi; Onoda, Toshiyuki; Ueshima, Hirotsugu

doi:10.2188/jea.15.194

Cited by 122 publications

(79 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a report from the Framingham study, 38 the prevalence of AF in male/female [1987][1988][1989]. Similarly, in Japan, AF has increased over time, [41][42][43] and is also expected to increase explosively in the future. 41,42 Osawa et al 41 and Inoue et al 42 separately estimated that the number of people with AF was approximately 700,000, and it is expected that will increase to more than 1,000,000 in 2020-2030, because of the increase in the aged population.…”

Section: Effect Of Increasing Body Size On Af In Clinical Practicementioning

confidence: 99%

Body Size and Atrial Fibrillation in Japanese Outpatients

Suzuki

Yamashita

Ohtsuka

et al. 2010

Circ J

View full text Add to dashboard Cite

Section: Effect Of Increasing Body Size On Af In Clinical Practicementioning

confidence: 99%

Body Size and Atrial Fibrillation in Japanese Outpatients

Suzuki

Yamashita

Ohtsuka

et al. 2010

Circ J

View full text Add to dashboard Cite

“…2 Patients with atrial fibrillation have a significantly increased risk of stroke and thromboembolic events, which results in an overall increase in mortality. 2,3 Factors that can lead to the development of cardiac arrhythmias include myocardial ischemia, electrolyte abnormalities, cardiomyopathy, and altered autonomic tone. The role of genetic variability in ion channels also has been linked to the development of arrhythmias in otherwise healthy individuals.…”

Section: Introductionmentioning

confidence: 99%

Teaching the Pharmacology of Antiarrhythmic Drugs

Zdanowicz

Lynch

2011

American Journal of Pharmaceutical Education

View full text Add to dashboard Cite

Objective. To provide doctor of pharmacy (PharmD) students with highly integrated, comprehensive and up-to-date instruction related to the pharmacology of antiarrhythmic drugs. Design. Students were taught the medicinal chemistry, pharmacology, and therapeutics of antiarrhythmic agents in the cardiology module presented in quarter 7 of the PharmD curriculum. Important foundational information for this topic was presented to students in prerequisite physiology courses and pathophysiology courses offered earlier in the curriculum. Emphasis was placed on student critical thinking and active involvement. Weekly recitation sessions afforded students the opportunity to apply the information they learned regarding arrhythmia pharmacotherapy to comprehensive patient cases. Assessment. Student comprehension was measured using class exercises, short quizzes, case writeups, comprehensive examinations, group exercises, and classroom discussion. Students were afforded the opportunity to evaluate the course, and the instructors as well as rate the degree to which the course achieved its educational outcomes. Conclusion. Students learned about cardiac arrhythmias through a high-quality, interdisciplinary series of classes presented by faculty members with extensive experience related to the pharmacology and pharmacotherapy of cardiac arrhythmias.

show abstract

“…1,2 The estimated number of Japanese adults with AF has doubled from 1980 to 2000 and is projected to increase further, afflicting nearly 1 million by 2030. 2 The association of aging with AF incidence is contextually important because Japan, together with many developed countries, has a rapidly aging population. 2 AF-associated stroke, heart failure and increased all-cause mortality are well appreciated in Japan and North America.…”

mentioning

confidence: 99%